Advertisement

Topics

"Evaluation Of Bilateral Tecnis Multifocal Versus ReSTOR 3D Intraocular Lenses" Drugs and Medication Database

01:20 EDT 22nd October 2018 | BioPortfolio

Here are the most relevant "Evaluation Of Bilateral Tecnis Multifocal Versus ReSTOR 3D Intraocular Lenses" Drugs and Medications that we have found in our database.

More Information about "Evaluation Of Bilateral Tecnis Multifocal Versus ReSTOR 3D Intraocular Lenses" on BioPortfolio

We have published hundreds of Evaluation Of Bilateral Tecnis Multifocal Versus ReSTOR 3D Intraocular Lenses news stories on BioPortfolio along with dozens of Evaluation Of Bilateral Tecnis Multifocal Versus ReSTOR 3D Intraocular Lenses Clinical Trials and PubMed Articles about Evaluation Of Bilateral Tecnis Multifocal Versus ReSTOR 3D Intraocular Lenses for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Evaluation Of Bilateral Tecnis Multifocal Versus ReSTOR 3D Intraocular Lenses Companies in our database. You can also find out about relevant Evaluation Of Bilateral Tecnis Multifocal Versus ReSTOR 3D Intraocular Lenses Drugs and Medications on this site too.

Showing "Evaluation Bilateral Tecnis Multifocal Versus ReSTOR Intraocular Lenses" Drugs and Medications 1–25 of 290

Possibly Relevant

Iopidine [Alcon Laboratories, Inc.]

IOPIDINE® (apraclonidine hydrochloride ophthalmic solution) 1% as baseSterile

Eye wash [Kareway Product, Inc.]

Drug Facts

Lastacaft [Allergan, Inc.]

These highlights do not include all the information needed to use LASTACAFT safely and effectively. See full prescribing information for LASTACAFT. LASTACAFT (alcaftadine ophthalmic solution) 0.25%Initial U.S. Approval: 2010

Lastacaft [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use LASTACAFT™ safely and effectively. See full prescribing information for LASTACAFT™. LASTACAFT™ (alcaftadine ophthalmic solution) 0.25%Initial U.S. Approval: 2010

Miostat [Alcon Laboratories, Inc.]

MIOSTAT®(CARBACHOL INTRAOCULAR SOLUTION, USP) 0.01%

Flarex [Alcon Laboratories, Inc.]

Flarex (fluorometholone acetate ophthalmic suspension) Sterile

Fml [Allergan, Inc.]

FML (fluorometholone ophthalmic suspension, USP) 0.1%

Optipranolol [Bausch & Lomb Incorporated]

OptiPranololmetipranolol ophthalmic solution 0.3%

Fluorometholone [Pacific Pharma, Inc.]

FLUOROMETHOLONE

Metipranolol [Bausch & Lomb Incorporated]

Metipranolol Ophthalmic Solution 0.3% (Sterile)

Metipranolol [Falcon Pharmaceuticals, Ltd.]

Metipranolol Ophthalmic Solution 0.3% Sterile Ophthalmic Solution Rx Only

Tysabri [Elan Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use TYSABRI safely and effectively. See full prescribing information for TYSABRI. TYSABRI (natalizumab) injection for intravenous useInitial U.S. Approval: 2004

Leader original formula eye drops [HANLIM PHARM. CO., LTD.]

Drug Facts

Miochol e [Novartis Pharmaceuticals Corporation]

Miochol

Isopto carpine [Alcon Laboratories, Inc.]

These highlights do not include all the information needed to use Isopto® Carpine safely and effectively. See full prescribing information for Isopto® Carpine. Isopto® Carpine (pilocarpine hydrochloride ophthalmic solution) 1%, 2%

Eylea [Regeneron Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA (aflibercept) Injection For Intravitreal Injection Initial U.S. Approval: 2011

Pilocarpine hydrochloride [Falcon Pharmaceuticals, Ltd.]

These highlights do not include all the information needed to use Pilocarpine Hydrochloride Ophthalmic Solution safely and effectively. See full prescribing information for Pilocarpine Hydrochloride Ophthalmic Solution. Pilocarpine Hydrochlor

Miochol e [Bausch & Lomb Incorporated]

Miochol-E

Visionblue [Dutch Ophthalmic Research Center International B.V.]

Brimonidine tartrate [STAT RX USA LLC]

Brimonidine [Akorn, Inc.]

Brimonidine Tartrate Ophthalmic Solution, 0.2%

Brimonidine tartrate [Bausch & Lomb Incorporated]

Brimonidine Tartrate Ophthalmic Solution 0.2% (Sterile)

Latanoprost [Greenstone LLC]

Latanoprost ophthalmic solution

Restasis [Physicians Total Care, Inc.]

RESTASIS (cyclosporine ophthalmic emulsion) 0.05%

Latanoprost [Apotex Corp.]

Latanoprost Ophthalmic Solution, 0.005%



Advertisement
Quick Search
Advertisement
Advertisement